Targeted Screening for Chronic Q Fever, the Netherlands

Emerg Infect Dis. 2022 Jul;28(7):1403-1409. doi: 10.3201/eid2807.212273.

Abstract

Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices located in outbreak areas selected 3,419 patients who had specific underlying medical conditions, of whom 1,642 (48%) participated. Immunofluorescence assay of serum showed that 289 (18%) of 1,642 participants had a previous Coxiella burnetii infection (IgG II titer >1:64), and 9 patients were suspected of having chronic Q fever (IgG I y titer >1:512). After medical evaluation, 4 of those patients received a chronic Q fever diagnosis. The cost of screening was higher than estimated earlier, but the program was still cost-effective in certain high risk groups. Years after a large Q fever outbreak, targeted screening still detected patients with chronic Q fever and is estimated to be cost-effective.

Keywords: Coxiella burnetii; Q fever; aneurysm; bacteria; chronic Q fever; cost effectiveness; general practitioner; heart valve disease; immunocompromised patient; screening program; targeted screening; the Netherlands; vascular disease.

MeSH terms

  • Antibodies, Bacterial
  • Coxiella burnetii* / genetics
  • Humans
  • Immunoglobulin G
  • Netherlands / epidemiology
  • Q Fever* / diagnosis
  • Q Fever* / epidemiology

Substances

  • Antibodies, Bacterial
  • Immunoglobulin G